Bemnifosbuvir — Investigational nucleotide antiviral targeting viral RNA polymerase; being developed with ruzasvir for hepatitis C.
Dasabuvir — Hepatitis C NS5B polymerase inhibitor.
Sofosbuvir — Nucleotide NS5B polymerase inhibitor central to curative hepatitis C combinations; amiodarone coadministration can cause serious bradycardia.